NanoViricides Inc. (NNVC)

[Trendliner]

THANK YOU KMBJN: THE FACTS/TRUTH SHALL SET YOU FREE

There indeed have been research successes. These were not made up "facts" as some allege.

The issue for NNVC is not that there have been no successes in the lab. The issue has to do with scalability and drug candidate optimization. These are engineering hurdles. Likely someday they will be solved. It appears as if Vecoy has had some success along these lines.

The problem for investors in NNVC relates estimating the probability that NNVC will be able to solve them. Thus far there is evidence that they have not. The market's opinion, as indicted by price, is consistent with a pattern of repeated engineering failures.

Trendliner